RxDoctor Payments Data

Orrin Davis

Pediatrics · Fayetteville, ARNPI 1083669329

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Corium, LLC at 39.4% of the total.

$1,187in general payments, 2019–2025

Across 70 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$468
  • Pfizer$240
  • Ironshore Pharmaceuticals Inc.$113
  • Supernus Pharmaceuticals, Inc.$94
  • Sanofi Pasteur Inc.$85
  • GSK$67
  • plus $119 from 7 others
$539,733in research payments, 2019–2025

Across 81 payments — averaging $6663.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$386K
  • AstraZeneca$79K
  • Astrazeneca UK Limited$75K

What the payments were for

  • Food & beverage$1,187100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,187 in reported general payments places this provider in the 85th percentile of 464 pediatrics providers in Arkansas.

See all pediatrics providers in Arkansas

Other pediatrics in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →